Some recent research and commentary have suggested that most or all the effects reported
by people who microdose psychedelics may be explained by expectations or placebo …

Background: Psychedelics are increasingly recognized as a promising and innovative
treatment strategy for several mental disorders. However, there is still a lively controversy in …

There is renewed interest in psychedelics, such as psilocybin, as therapies for multiple
difficult-to-treat psychiatric disorders. Even though psychedelics can induce highly pleasant …

Background Peripheral levels of brain-derived neurotrophic factor (BDNF) are often used as
a biomarker for the rapid plasticity-promoting effects of ketamine, psychedelics, and other …

Introduction Enhanced creativity is often cited as an effect of microdosing (taking repeated
low doses of a psychedelic drug). There have been recent efforts to validate the reported …

Treating amotivated states remains difficult. Classical psychedelic drugs (5-HT 2A receptor
agonists) such as LSD and psilocybin have shown therapeutic potential in treating such …

Psychedelics are emerging as potential treatments for a range of mental health conditions,
including anxiety and depression, treatment-resistant depression, and substance use …

Executive function deficits, common in psychiatric disorders, hinder daily activities and may
be linked to diminished neural plasticity, affecting treatment and training responsiveness. In …

In recent years, the scientific community has started to unveil one of the most intriguing
possibilities of treatment of modern times: the use of psychedelics to induce or promote …